Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03192059
Brief Title: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (PRIMMO)

First Submitted : May 29, 2017
First Submitted that Met QC Criteria : June 15, 2017
First Posted : June 19, 2017

Last Update Submitted that Met QC Criteria : September 6, 2021
Last Update Posted : September 8, 2021